Do over the counter cough medicines not work?

New study on over the counter cough medicines Researchers at RCSI (Royal College of Surgeons in Ireland) found no substantial evidence that over the counter medicines are effective in treating short term coughs in children or adults. The research, carried out by the Health Research Board (HRB) Centre for Primary Care Research, Department of General…

Read More

UK:New quality standards – rare cancer and lung disorder

New quality standards for rare cancer and lung disorder NICE has issued 2 quality standards for care of people with sarcoma and idiopathic pulmonary fibrosis to ensure they have access to the right health and social care professionals. Sarcoma describes a rare group of cancers that develop in the cells responsible for supporting body tissues…

Read More
European Institute of womens health, Eurohealth health logo

European Cervical Cancer Week, 2015

Press release The European Institute of Women’s Health (EIWH) supports European Cervical Cancer Week Jan 25-31st 2015 The prevention of cervical cancer has the potential to become a major public health success  story. We should be able to lower rates of cervical cancer even further, if best practice in early detection through cancer screening and…

Read More

ie: Fitness to Practise – Irish Health and Social Care

Fitness to Practise for Irish based Health and  Social Care Professionals CORU, the Health and Social Care Professional Regulator will ensure professional standards are met, so protecting the public. The designated professions are social workers, clinical biochemists, dietitians, medical scientists, occupational therapists, orthoptists, physiotherapists, podiatrists, psychologists, radiographers, social care workers and speech and language therapists.…

Read More

UK: New type 2 diabetes treatment option

Type 2 diabetes drug empagliflozin Draft guidance recommends empagliflozin for treating type 2 diabetes after preliminary appraisal last August. NICE called for more evidence to demonstrate that empagliflozin was a good use of NHS resources compared with other already available treatments. Boehringer Ingelheim submitted a new cost effectiveness model showing that empagliflozin combination therapy is…

Read More

UK: New committee to improve levels of care

Joint committee to improve care in general practice and healthcare commissioning. The new NICE Indicator Advisory Committee replaces the Quality and Outcomes Framework (QOF) Advisory Committee and the Clinical Commissioning Group Outcome Indicator Set (CCG OIS) Advisory Committee. The new committee will comprise GPs, hospital clinicians, lay members and experts representing nursing, pharmacy, public health,…

Read More

Prostate cancer treatment too expensive!

Sipuleucel-T cost too high for prostate cancer patients Final draft guidance not recommending sipuleucel-T for use with: Prostate cancer in men whose disease has spread, Who have few symptoms and with disease not yet suitable for chemotherapy treatment. Evidence showed price to NHS too high for potential benefit it may provide to patients. Sipuleucel-T, known…

Read More